Aragen Bioscience and Innovent Biologics have entered a collaboration for the development and manufacture of cell lines for biotherapeutic product development. Aragen Bioscience will develop CHO cell lines and assess critical product quality attributes for various antibodies and protein therapeutics.             “Aragen Bioscience has demonstrated expertise in cell line development and protein product characterization. We recently completed the first technology transfer of the collaboration and ...